Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder in childhood. The psychostimulant methylphenidate is the most frequently used medication to treat it. Several studies have investigated the benefits of methylphenidate, showing possible favourable effects on ADHD...

Celý popis

Podrobná bibliografie

Vydáno v:	Cochrane database of systematic reviews Ročník 5; s. CD012069
Hlavní autoři:	Storebø, Ole Jakob, Pedersen, Nadia, Ramstad, Erica, Kielsholm, Maja Lærke, Nielsen, Signe Sofie, Krogh, Helle B, Moreira-Maia, Carlos R, Magnusson, Frederik L, Holmskov, Mathilde, Gerner, Trine, Skoog, Maria, Rosendal, Susanne, Groth, Camilla, Gillies, Donna, Buch Rasmussen, Kirsten, Gauci, Dorothy, Zwi, Morris, Kirubakaran, Richard, Håkonsen, Sasja J, Aagaard, Lise, Simonsen, Erik, Gluud, Christian
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 10.05.2018
Témata:	Adolescent Attention Deficit Disorder with Hyperactivity - drug therapy Central Nervous System Stimulants - adverse effects Central Nervous System Stimulants - therapeutic use Child Child, Preschool Humans Methylphenidate - adverse effects Methylphenidate - therapeutic use Non-Randomized Controlled Trials as Topic Patient Dropouts - statistics & numerical data Young Adult
ISSN:	1469-493X, 1469-493X
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!